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Abstract: The incidence of human infections caused by the opportunistic fungal pathogen Candida
albicans is on the rise due to increasing numbers of immunosuppressed patients. The importance
of the immune system in preventing overgrowth of the colonizing fungus and thereby limiting
infection is well recognized and host protective mechanisms widely investigated. Only recently,
it was recognized that the natural diversity in the fungal species could also influence the outcome of
the interaction between the fungus and the host. C. albicans strain-specific differences are complex
and their regulation at the genomic, genetic, and epigenetic level and by environmental factors
is only partially understood. In this review, we provide an overview of the natural diversity of
C. albicans and discuss how it impacts host-fungal interactions and thereby affects the balance
between commensalism versus disease.
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1. Introduction
Candida albicans is found as a commensal in the human oral, gastrointestinal, and reproductive
tracts in a large proportion of healthy individuals, but it may become pathogenic when host
defenses are breached or under condition of microbial dysbiosis. C. albicans disease symptoms
range from mild to more severe superficial infection of the oral and vaginal mucosa, the skin, and the
nails [1–3], affecting many millions of people worldwide [4]. More rarely, C. albicans reaches the
bloodstream and disseminates to internal organs to cause systemic disease associated with high
mortality rates [5]. While the integrity of epithelial barriers and a functional immune system are well
known key determinants for protection against opportunistic C. albicans infections, it has become
clear that variations in the fungal species contribute additional risk factors for disease development
in susceptible hosts. Diversity in C. albicans can affect the morphology, the fungal behavior at
the host interface, the growth rate, and resistance to stressors, such as antimicrobial peptides or
antifungals. The transitions between different morphotypes (yeast, hyphae, pseudohyphae) and cell
types (white, opaque, grey, gastrointestinally induced transition (GUT) cells) are reversible processes,
mainly determined by the host environment and thus difficult to study in vitro.
Although variations between C. albicans natural isolates were noticed decades ago [6], most of the
current understanding of C. albicans-host interactions is based on experimental studies with a limited
number of strains, first and foremost the highly virulent strain SC5314. Only a few studies so far have
examined the consequences of the fungal diversity on the outcome of infection. Most attempts to
link specific genomic variations in C. albicans with phenotypic changes focused on drug resistance [7].
However, expression of virulence factors and the interaction with host cells also vary between genetic
backgrounds of C. albicans and can greatly impact on the pathogenicity of the fungus during systemic
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and mucosal infections [8–10]. To provide an example, differences in the composition of the fungal
cell wall and in the exposure of β-glucan between C. albicans isolates was found to determine the
requirement for the fungal receptor Dectin-1 expressed primarily by myeloid immune cells during
experimental systemic infection [11] and to influence the competitive fitness of the fungus in the
murine gastrointestinal tract [12].
Together, these studies highlight the relevance of the intraspecies diversity of C. albicans
for the outcome of the fungal-host interaction. However, the current knowledge about relevant
fungal differences that explain the diverging behavior of natural C. albicans isolates in the host
remains incomplete. In this review, we discuss the current understanding of the genetic, genomic,
and phenotypic variations that have been described in C. albicans and how they modulate the outcome
of the interplay with the host.
2. Host Responses to C. albicans
As a commensal, C. albicans is in constant interaction with the host epithelium. Progression from
commensalism to infection implies numerous changes in the interplay between the fungus and the
host, including enhanced adhesion, invasion, and induction of epithelial damage [13]. Epithelial cells
can differentiate between more or less pathogenic forms of C. albicans, in response to which they
activate distinct signaling pathways [14]. Recently a novel epithelial receptor, EphA2, required for
maximum antifungal response was identified. It binds to β–glucan and thereby senses the epithelial
fungal cell burden [15].
Tissue-invading fungi trigger the release of danger-associated molecules including alarmins
such as interleukin-1α (IL-1α) and chemokines that promote the recruitment of neutrophils and
inflammatory monocytes to the site of infection [16] where they contribute to antifungal defense [17,18].
Both the tissue resident and newly recruited myeloid cells of the innate immune system sense C.
albicans. Recognition of fungal carbohydrates and other pathogen associated molecular patterns
(PAMPs) in the fungal cell wall via pathogen recognition receptors (PRRs), in particular those of the
C-type lectin receptor (CLR) family, leads to immune activation and the production of cytokines [19].
It can also promote the induction of adaptive immunity, including the generation of interleukin-17
(IL-17)-producing lymphocytes. IL-17 plays a unique role in protecting the mucosal epithelium from
C. albicans, presumably by promoting the production of antimicrobial peptides [20,21]. Host defense
against systemic candidiasis is dominated by the action of neutrophils and monocytes, which prevent
fungal (over)growth and dissemination [22]. Neutrophils however can also drive immunopathology in
certain settings [23,24]. Moreover, neutrophils are believed to promote significantly the development
of disease symptoms during vulvovaginal candidiasis (VVC) [25].
The relative contribution of individual immune pathways to the host defense against C. albicans
may vary in a strain-dependent manner. This was exemplified recently in the experimental mouse
model of oropharyngeal candidiasis (OPC), where fungal strains were found to vary in their
capacity to persist in the host [10]. Interestingly, the source of the isolates did not seem to correlate
with pathogenicity [10]. This was also true when strains were assessed in different experimental
models [26,27]. In the OPC model, a high degree of damage induction by C. albicans strains correlated
with strong inflammatory response and rapid fungal clearance, while strains inducing low epithelial
cell damage triggered only a low degree of inflammation and in consequence colonized the host
persistently [10]. In contrast, IL-17 and its target genes were strongly induced by both high and low
virulent strains indicating that the IL-17 pathway does not hinder fungal colonization, although it can
prevent fungal overgrowth in both cases [10]. These findings show the importance of strain variations
in modulating disease outcome. Still, more research is required to obtain a broader understanding
of strain-specific versus conserved antifungal defense mechanisms in different host tissues. Also,
it remains to be seen how these findings translate to the human host as all current data on how fungal
diversity can impact the fungal-host interplay stem from experiments in vitro and in experimental
mice, in which C. albicans is not a commensal.
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3. Genetic and Genomic Variations
C. albicans is a highly successful organism, both as a commensal and a pathogen. This is thought
to be—at least in part—due to the high degree of plasticity of its genome, which enables the fungus to
grow in many different niches in the human host and to rapidly adapt to extreme stress conditions
such as those imposed by the host immune system or by antifungal drugs [28]. Genomic variations are
found in commensal isolates [29], but they may also be acquired and further enriched under stress
conditions [30,31].
The diploid genome of C. albicans is approximately 14.4 megabases in size and organized in 8
chromosomes [32,33]. Based on multilocus sequence typing, the natural C. albicans population has
been stratified in at least 18 phylogenetic groups (clades) [34]. Recent advances in whole genomic
sequencing have further advanced the understanding of the genomic organization of C. albicans [9,35].
C. albicans populations isolated from the human host are mainly clonal when analyzed by multilocus
sequence typing or similar approaches, suggesting that this diploid fungus reproduces predominantly
clonally [36–38]. There is also evidence for low levels of DNA recombination in the population,
possibly due to parasexual mating [39].
The genome is largely heterozygous, and heterozygosity is thought to be an important virulence
trait of C. albicans [40]. Haploid forms of C. albicans have been isolated and found to be viable, but they
show marked defects in fitness and virulence [41]. The observation that auto-diploids show the same
fitness defects as haploids highlights the benefit of heterozygosity for the fungus [41]. Variations
in chromosome organization and copy number can rapidly generate diversity and thereby allow
adaptation to changes in the environment of the fungus [42].
Loss of heterozygosity (LOH) is a major mechanism to generate genetic diversity in populations of
heterozygous organisms [43,44]. Passaging C. albicans through the murine host was found to enhance
LOH, indicating that host signals such as oxidative stress are a main driver of the process [45]. LOH can
also occur upon exposure to antifungal drugs [30] and other environmental stresses [46]. The adaptive
benefits of LOH under selective pressure may result from alterations in gene expression levels or the
selection of mutant alleles [47].
Aneuploidy, the loss or additional presence of one or more chromosomes, represents an alternative
mechanism for how C. albicans can rapidly adapt to stressful environments. Aneuploidy of a specific
chromosome can confer phenotypic changes by virtue of the copy number of specific genes on that
chromosome relative to the copy number of other genes [28]. Although the presence of aneuploid
chromosomes often carries a fitness cost, such as the reduction in growth rate, higher demands
associated with DNA replication, and difficulty in segregating aneuploid chromosomes [48–50],
aneuploidy can provide a selective advantage under stress conditions [42]. This has also been observed
in other fungal pathogens such as Cryptococcus neoformans [44]. Several studies have documented
how specific aneuploidies can directly confer drug-resistance in clinical isolates of C. albicans [51–53].
Aneuploidy also likely contributes to adaptation of C. albicans in the host as in vivo passaging of strains
through a mouse was shown to induce aneuploid formation [45]. Because aneuploidy is often unstable
when the fungus is kept under rich medium growth conditions, it may be rapidly lost after removal
from the host niche and, thus, difficult to detect ex vivo [54].
In addition to LOH and aneuploidy, recombination between homologous chromosomes including
gene conversion events can also impact on the phenotype of C. albicans [55]. This was described
for instance during the parasexual cycle of C. albicans by concerted chromosome loss linked to
recombination events [56]. Thereby, the reproductive cycle may also contribute to generating genomic
variation in the fungus [57]. In conclusion, the remarkable genome plasticity observed in C. albicans
represents a central mechanism of adaptive evolution promoting the fitness of the fungus, resistance to
environmental stress, and interaction with the host.
Additional mechanisms of phenotypic diversification in C. albicans are achieved by sequence
variations in coding or non-coding regions and at the transcriptional, translational, and post-translational
level. The best studied examples of variations that affect the nucleotide sequence of individual genes
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are from drug resistance studies. There, mutations in genes encoding antifungal targets (e.g., ERG11,
FKS1) and drug efflux pumps (e.g., CDR1, CDR2, MDR1) have been discovered and explain the
progressive increase in resistance of isolates that have been exposed to antifungal treatments [58,59].
The expression of many C. albicans virulence genes is differentially regulated by environmental
factors and/or in a cell-type specific manner (see below for hyphal-specific gene regulation). It is
further influenced by differential chromatin states that are important in adaptation processes. Dynamic
remodeling of telomeric heterochromatin occurred upon environmental changes [60]. The histone
acetyl transferase Hat1 was found to mediate oxidative stress tolerance and resistance to azoles in
C. albicans [61]. Moreover, DNA methylation in C. albicans was linked to morphological switching and
iron metabolism, both processes important for virulence [62]. Therefore, epigenetic modulations add
another level of plasticity, which may result in strain-specific differences.
Posttranscriptional regulatory mechanisms of genes involved in pathogenesis and morphology have
also been described in C. albicans, including the regulation of mRNA stability and localization [63,64].
At the translational level, phenotypic variation is enhanced by the atypical codon usage at CUG
sites incorporating serine instead of leucine and a remarkable codon assignment flexibility [65,66].
This adaptive mistranslation creates genomic alterations that can affect fungal growth and fitness in
particular under selective pressure as exemplified by fluconazole administration [67].
An additional posttranslational mechanism, with impact on C. albicans morphogenesis, virulence
and drug resistance is mediated by the acetylation of the heat-shock family protein Hsp90 thereby
promoting its function as a stress response regulator [68,69]. Some virulence factors are also regulated
at the posttranslational level through enzymes such as aspartic proteases or phospholipases that
modulate the function of their targets under specific environmental conditions [70,71].
Together, these examples highlight the plethora of mechanisms that C. albicans uses to increase its
adaptive flexibility in response to environmental cues, host factors, and antifungal stressors.
4. Morphotype Variations
C. albicans exist in distinct morphological forms, including yeast, hyphae, and pseudohyphae.
They differ in size, shape, cellularity, and in their mode of division. While unicellular spherical
yeast cells reproduce by budding, tube-shaped hyphal cells remain firmly attached one to another to
produce multicellular filamentous structures [72]. Ellipsoid-shaped pseudohyphal cells have features
of both yeasts and hyphae. They consist of strings of elongated yeast cells that fail to separate, but in
contrast to hyphae, they have constrictions at the sites of septation and are wider than hyphae [72,73].
Diverse environmental and host conditions promote the reversible transition between the distinct
morphotypes including contact of C. albicans to body surfaces, exposure to host cell molecules and/or
changes in oxygen availability and carbon sources [74], or influences from the microbiota and their
metabolites [75]. These host conditions can at least in part be simulated by elevated temperature (37 ◦C),
adhesion to inert surfaces, or the presence of serum to promote morphotype switching in vitro [72].
In addition to environmental cues that regulate the balance between different C. albicans
morphotypes, the genetic variation in the species determines the propensity of individual strains to
form hyphae or pseudohyphae. Changes in the sequence and/or expression of cell type-specific genes
can greatly impact the morphology of a strain and thereby the functional diversity that is observed
within the species overall.
Hyphal morphogenesis is coupled to virulence. This is best characterized for yeast and hyphae,
while the role of pseudohyphae is less well understood. Yeast cells are generally viewed as the
commensal form colonizing the mucosal epithelia, while hyphae are the more pathogenic form,
promoting epithelial invasion that leads to disease symptoms [76]. In the context of systemic infections,
yeast cells facilitate dissemination of the fungus through the blood stream, whereas the transition into
the filamentous form is a prerequisite for induction of pathology by the fungus [77]. Mutants unable
to switch between the yeast and hyphal form are compromised in virulence [78,79]. This is linked
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to a different capacity of the individual C. albicans morphological forms to interact with and invade
the host.
Major changes occur in the structure and composition of the fungal cell wall upon morphotype
switching [76]. This entails alterations in the interaction of C. albicans with host cells via CLRs and
other PRRs and in the ensuing innate and adaptive antifungal immune response [80]. Moreover,
yeast and hyphal cells display important differences in their capacity to adhere, invade, and cause
damage to epithelial cell barriers. The fungal molecules that mediate these processes are under
the control of the hyphal gene expression program [81]. These include adhesins (e.g., Hwp1 and
Als3), invasins (e.g., Als3), and tissue-degrading enzymes such as secreted aspartyl proteinases and
phospholipases [82–84]. Likewise, the gene encoding a recently identified cytolytic peptide toxin
Ece1, a key fungal determinant responsible for the induction of host cell damage [85], is selectively
expressed during hyphal growth. However, Ece1 is not essential for filamentation as an ECE1-deletion
mutant has no defect in hyphae formation [85], underlining that filamentation and damage induction
are two separate processes. The capacity to induce epithelial damage greatly varies between natural
C. albicans isolates [10]. The role of Ece1 in damage induction may be strain specific as no correlation
between Ece1 expression and the level of damage induction was found so far across a number of
natural isolates [10]. In the murine OPC model, differences in epithelial damage translate into variable
degrees of inflammation and immune cell recruitment to the infected tissue and, in turn, result in
either clearance or persistence of the fungus in the oral mucosa [10].
Besides yeast, hyphae, and pseudohyphae, additional much rarer growth forms of C. albicans
have been described. For instance, the production of chlamydospores [86] or highly resistant persister
cells [87] were observed under environmental conditions characterized by low nutrient availability
or elevated stress. Moreover, some strains of C. albicans can show flake-like growth. In these strains,
budding yeast cells stay attached and do not separate from the mother cell, resulting in yeast cell
aggregates. Mutations in the promotor FLO1 and the transcription factor Ace2 were found to cause this
aggregative growth in C. albicans [88,89]. Interestingly, flake-like multicellular yeast growth creates a
bottleneck for evolution and, thus, might be beneficial for adaptation to a host environment, as clusters
of genetically identical cells (not single cells) are exposed to selective pressures and thus enable faster
adaptation [90].
Mixed populations of C. albicans yeast, hyphae, and pseudohyphae are observed in biofilms [91,92].
These densely packed communities of cells encased in extracellular matrix preferentially grow on
mucosal surfaces or solid substrates such as catheters. They constitute a major virulence attribute of
C. albicans because of their high intrinsic resistance to antibiotics and the mammalian immune system.
Biofilm formation may also vary between strains [93].
From an evolutionary perspective, populations with high morphological variability may be better
equipped to adapt to fluctuating environmental conditions. Selective pressure will enable survival and
propagation of the cells with the highest fitness and, subsequently, lead to adaptation of the strain.
This may be of clinical relevance as versatile fungal strains will be able to better persist in the presence
of host defenses or antifungals.
5. Niche-Specific Morphology Switching
In addition to the classical ‘white’ yeast cells described above, C. albicans can adopt several
additional yeast cell-like morphologies [91]. Opaque, grey, and GUT cells have an elongated shape
compared to their round-to-oval shaped white counterpart and they exhibit distinct properties. While
white cells survive and thrive in a variety of different environments, opaque, grey, and GUT cells
exhibit enhanced fitness only in specific host niches. Their preference for specific host niches is
reflected in their metabolic program. While white cells display a transcriptional signature of using
fermentation pathways and glycolysis, opaque cells preferentially use pathways involved in oxidative
respiration [94]. They were shown to have a high fitness in a neonatal mouse skin colonization
model [95]. Grey cells are selectively induced by exposure to nutrient-rich growth medium and display
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a particularly high growth rate in an ex vivo tongue infection model [94]. GUT cells in contrast display
the highest fitness in the gastrointestinal (GI) tract but not in other environments of experimentally
colonized mice [96]. Thus, a common feature of these newly described elongated yeast-like phenotypes
may be their specialization for commensalism.
Switching between the different yeast-like cell types is a transient and reversible process that
strictly depends on environmental factors. White-opaque switching, although occurring stochastically
and at low frequency, can be promoted by N-acetylglucosamine, hypercarbia, and an acidic pH [97–100].
While it was long thought that white cells, which are usually heterozygous (a/α) at the mating type
locus (MTL), need first to undergo homozygosis to a/a or α/α to become switching-competent, it is
now clear that heterozygous a/α cells are also able to switch to the opaque state [95]. White-to-opaque
switching is under the control of the master regulators Wor1 and Wor2 [97,101] that act in a circuit of
transcriptional regulators which further include the recently identified regulator Wor4 [102] and the
transcriptional repressor Ssn6 [103]. In addition to transcriptional regulation, epigenetic mechanisms,
e.g., histone deacetylation, were also found to regulate white-opaque switching [104]. Treatment of
C. albicans with a histone deacetylase inhibitor or selective genetic targeting of the histone deacetylase
HDA1 increased switching from the white to the opaque state [105]. The combined use of antifungals
with histone deacetylase inhibitors, to reduce fungal adaptation towards drug resistance, might thus
represent a promising therapeutic strategy [106].
The capacity of C. albicans to switch between the white and opaque state is a prerequisite for the
fungus to mate. Only opaque cells that are haploid at the mating type locus are mating competent [107].
Mating occurs between two opaque cells with opposite mating type that fuse to produce diploid a/α
cells followed by chromosome loss in tetraploid cells and possibly genomic recombination [108].
Thereby, this parasexual circle creates phenotypic diversity in C. albicans with an impact on host
virulence and resistance [57]. Besides the link to mating, which is rare in C. albicans, white-opaque
switching may represent an immune evasion strategy. In contrast to their white counterparts, opaque
cells are more resistant to phagocytosis by host cells [109–111] and do not release chemoattractants
for polymorphonuclear leukocytes [112]. Opaque cells have also been shown to display an altered
sensitivity to at least some antifungal drugs [113]. Under specific conditions, opaque cells can form
hyphae similarly to white cells, although the filamentation program largely differs between the two
cell types [114]. Opaque cells have been shown to filament also in vivo to establish a lethal infection,
at least at low temperature [111].
Although it has become clear that the phenotypic plasticity contributes to C. albicans’ ability
to colonize and infect different host niches, more research is needed to gain a comprehensive view
of the regulation of different cell types in vivo in different host niches and how they impact the
fungus-host interaction.
6. Conclusions
Although impaired immune functions and microbial dysbiosis in the host remain the primary
determinants of opportunistic C. albicans infections, variations within the fungal species significantly
contribute to the development and severity of disease symptoms. Diversity exists at multiple
levels ranging from nucleotide to morphological differences. Heterogeneity at the genomic, cellular,
or population level facilitates adaptation to environmental changes and enhances the competitive
fitness of the fungus in diverse host niches.
Understanding the complex regulation of the phenotypic and functional variations in C. albicans
remains a major challenge. While several studies have explored how functionally distinct strains affect
the interaction with the host, the molecular basis for the observed phenotypic differences remains
unclear in most cases. The field is awaiting identification of specific genetic and genomic variations that
translate into relevant phenotypic changes in C. albicans to affect the balance between commensalism
and pathogenicity in different host niches.
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Studying the diversity of C. albicans is complicated by the transient and reversible nature of many
of the fungal variations, including the diverse morphotypes as well as their strict dependence on host
environmental factors. They may not remain stable once removed from the host context. Moreover,
the lack of standardized protocols for studying the niche-specific cell types hampers the comparison of
results from different laboratories.
Key open questions include how variations in the host and in the microbiota can create diversity
in the fungal species and how they may promote the switch in C. albicans from commensalism to
pathogenicity. While many examples exist for how C. albicans adapts to antifungals, there is a current
gap in knowledge on how the immune system and the microbiota modulate fungal genetics and
genomics during commensalism and pathogenicity. A better understanding of these processes will
contribute to the development of novel and possibly personalized strategies to predict and improve
patient outcome.
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